Zai Lab Ltd. (ZLAB)
21.55
-0.09
(-0.42%)
USD |
NASDAQ |
May 01, 16:00
21.55
0.00 (0.00%)
After-Hours: 16:33
Zai Lab EPS Diluted (Quarterly) : -0.4578 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| 111, Inc. | -0.2611 |
| Concord Medical Services Holdings Ltd. | -- |
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.63M |
| Revenue (Quarterly) | 128.15M |
| Total Expenses (Quarterly) | 178.78M |
| Enterprise Value | 1.860B |
| Gross Profit Margin (Quarterly) | 51.15% |
| Profit Margin (Quarterly) | -39.51% |
| Earnings Yield | -7.46% |
| Normalized Earnings Yield | -7.400 |